This post was written by Victoria Rodriguez, Advocacy Associate, and Danielle Heiberg, Senior Manager, Policy & Advocacy.

Appropriations Update

FY 2019 and the end of the fiscal year

In the last few days of the fiscal year (FY), which ends on September 30, Congress is working to pass remaining FY 2019 spending bills packaged as “minibuses” – several spending bills packaged together.

The Senate passed a minibus that includes the Labor, Health and Human Services, and Education and the Defense spending bills (H.R. 6157), which contains funding for programs at NIH and CDC. The minibus is now in the House, with a vote expected this week. The minibus includes increases or sustained funding for global health programs.

NIH is funded at $39 billion (increase of $2 billion), and includes:

  • $78.1 million for the Fogarty International Center (increase of $2 million)
  • $5.5 billion for NIAID (increase of $263 million)

CDC is funded at $7.89 billion (increase of $127 million), and includes:

  • $488.6 million for the Center for Global Health (maintained from FY 2018), including an addition of $50 million for the Infectious Disease Rapid Response Reserve Fund
  • $620.3 million for Center for Emerging Zoonotic and Infectious Diseases (increase of $6 million)

The minibus also contains a Continuing Resolution (CR) that will fund the remaining appropriations bills, including the State and Foreign Operations bill, until December 7. Despite President Trump sending mixed signals on whether he will sign the minibus, House Republican Leadership believe they can avert a government shutdown.

GHC Meets with OMB to Discuss FY 2020

While Congress is in the midst of solidifying appropriations for FY 2019, Global Health Council and the global health community completed funding recommendations for FY 2020 for review by the Office of Management and Budget (OMB). Recently, GHC and a small group of GHC members met with OMB to provide the recommendations and to discuss the critical importance of continued commitment to cost-effective global health programs by the United States.

View GHC’s FY 2020 letter to OMB.

PEPFAR Reauthorization Introduced in the Senate

On September 18, Senators Bob Corker (R-TN) and Bob Menendez (D-NJ) introduced legislation to reauthorize PEPFAR (S.3476) through 2023. The Senate Foreign Relations Committee has placed the bill on the agenda of its next business meeting on Wednesday, September 26; the bill is expected to move quickly through the Senate. The text of the bill may be reviewed here once available to the public.

In late summer, Representatives Chris Smith (R-NJ) and Barbara Lee (D-CA) introduced similar legislation (H.R. 6651) in the House.